Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Metabolic investigation in patients with nephrolithiasis.

Santos FMD, Peres AK, Mandotti MR, Peres LAB.

Einstein (Sao Paulo). 2017 Oct-Dec;15(4):452-456. doi: 10.1590/S1679-45082017AO4029. Epub 2017 Dec 18. English, Portuguese.

2.

Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.

Kim S, Chang Y, Sung E, Kim CH, Yun KE, Jung HS, Shin H, Ryu S.

PLoS One. 2017 Oct 26;12(10):e0184506. doi: 10.1371/journal.pone.0184506. eCollection 2017.

3.

Postmenopausal hormone and the risk of nephrolithiasis: A meta-analysis.

Yu J, Yin B.

EXCLI J. 2017 Jun 30;16:986-994. doi: 10.17179/excli2017-304. eCollection 2017.

4.

Atorvastatin, a double weapon in osteoporosis treatment: an experimental and clinical study.

El-Nabarawi N, El-Wakd M, Salem M.

Drug Des Devel Ther. 2017 May 2;11:1383-1391. doi: 10.2147/DDDT.S133020. eCollection 2017.

5.

A large 15 - year database analysis on the influence of age, gender, race, obesity and income on hospitalization rates due to stone disease.

Mello MF, Marchini GS, Câmara C, Danilovic A, Levy R, Eluf-Neto J, Srougi M, Mazzucchi E.

Int Braz J Urol. 2016 Nov-Dec;42(6):1150-1159. doi: 10.1590/S1677-5538.IBJU.2015.0743.

6.

Insights Into Nephrolithiasis From the Nurses' Health Studies.

Prochaska ML, Taylor EN, Curhan GC.

Am J Public Health. 2016 Sep;106(9):1638-43. doi: 10.2105/AJPH.2016.303319. Epub 2016 Jul 26. Review.

7.

Combined vitamin D and calcium supplementation in vitamin D inadequate patients with urolithiasis: Impact on hypercalciuria and de novo stone formation.

Hesswani C, Noureldin YA, Elkoushy MA, Andonian S.

Can Urol Assoc J. 2015 Nov-Dec;9(11-12):403-8. doi: 10.5489/cuaj.3332. Epub 2015 Dec 14.

8.

Stone composition as a function of age and sex.

Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, Moyer TP.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2141-6. doi: 10.2215/CJN.05660614. Epub 2014 Oct 2.

9.

Nigella Sativa reverses osteoporosis in ovariectomized rats.

Seif AA.

BMC Complement Altern Med. 2014 Jan 14;14:22. doi: 10.1186/1472-6882-14-22.

10.

Epidemiology of urolithiasis: an update.

Trinchieri A.

Clin Cases Miner Bone Metab. 2008 May;5(2):101-6.

11.

Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements.

Wallace RB, Wactawski-Wende J, O'Sullivan MJ, Larson JC, Cochrane B, Gass M, Masaki K.

Am J Clin Nutr. 2011 Jul;94(1):270-7. doi: 10.3945/ajcn.110.003350. Epub 2011 Apr 27.

12.

Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats.

Saleh NK, Saleh HA.

BMC Complement Altern Med. 2011 Feb 4;11:10. doi: 10.1186/1472-6882-11-10.

13.

Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.

Maalouf NM, Sato AH, Welch BJ, Howard BV, Cochrane BB, Sakhaee K, Robbins JA.

Arch Intern Med. 2010 Oct 11;170(18):1678-85. doi: 10.1001/archinternmed.2010.342.

14.

Kidney stones.

Parmar MS.

BMJ. 2004 Jun 12;328(7453):1420-4. Review. No abstract available.

Supplemental Content

Support Center